Eckert & Ziegler nabs nuclitec for $8.7M
The Berlin-based Eckert & Ziegler Strahlen-und Medizintechnik has taken over all shares of the Braunschweig, Germany-based company nuclitec and its French and U.S.-based sister companies, nuclitec sarl and nuclitec Inc.
The purchase price agreed on for the companies and for the cash reserves remaining in the companies was €6.6 million ($8.7 million U.S.). A capital increase is currently being implemented to partly finance the transaction, according to the company.
“To increase profitability, we will during the next months need to implement a number of structural changes, but Braunschweig itself as a production site will remain. Also, we are excited about the interesting future fields of activity that nuclitec will contribute, in particular the clean-room manufacturing of the radiopharmaceutical Yttrium-90,” said Andreas Eckert, MD, CEO of Eckert & Ziegler.
The purchase price agreed on for the companies and for the cash reserves remaining in the companies was €6.6 million ($8.7 million U.S.). A capital increase is currently being implemented to partly finance the transaction, according to the company.
“To increase profitability, we will during the next months need to implement a number of structural changes, but Braunschweig itself as a production site will remain. Also, we are excited about the interesting future fields of activity that nuclitec will contribute, in particular the clean-room manufacturing of the radiopharmaceutical Yttrium-90,” said Andreas Eckert, MD, CEO of Eckert & Ziegler.